in patients with peripheral arterial. Relationships between Walking Impairment Questionnaire scores results News and. span class=fFile CATHOLIC ENCYCLOPEDIA: Saint Format:span PDFAdobe Acrobat - a as HTMLa span class=fFile Format:span PDFAdobe Acrobat - a as HTMLa Could ramipril improve walking distance in peripheral
arterial disease?. exercise testing, and scores on a Walking Impairment Questionnaire (WIQ).. This trial also incorporated assessment of walking impairment by a disease specific questionnaire. Using this 'Walking Impairment A long-term
(mean 9.3 years) follow-up examination of survivors was performed, including physical evaluation, walking impairment questionnaire (WIQ),. Secondary
and clinical success, and quality of life assessed by a walking impairment questionnaire (in the.
scale, Walking Impairment Questionnaire (WIQ) [10] and quality of life instruments such as Intermittent Claudication
[11]. of the Walking Impairment Questionnaire and other novel. measures of walking impairment). Outcomes and analysis. The following outcomes were assessed:. There was no significant
difference between treatments in quality of life